Arialys

Arialys Therapeutics

La Jolla, United States · Founded 2022 · $72.8M raised

Headquarters
La Jolla
Employees
1–10
Founded
2022
Business Model
B2B
Total Funding
$72.8M
Last Round
$14.8M Venture RoundJun 2025
Rounds
2

About

Arialys Therapeutics is a clinical-stage biotechnology company based in La Jolla, California, developing precision medicines that target autoimmune neuropsychiatric diseases, including anti-NMDA receptor encephalitis. The company was founded by Avalon Bioventures, Catalys Pacific, and MPM to explore recent discoveries in autoimmune neuropsychiatry, with a focus on blocking disease-causing pathogenic antibodies. Its lead candidate, ART5803, holds FDA Rare Pediatric Disease designation.

Summary

Arialys is a Biotech company based in La Jolla, United States, founded in 2022. It has raised $72.8M in total across 2 rounds, most recently a $14.8M Venture Round round in Jun 2025. Investors include Avalon BioVentures, Alexandria Venture Investments and Catalys Pacific.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundJun 2025
$14.8M

Sign up to see all 2 rounds

Seed through Venture Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Arialys on Indexed.vc
<a href="https://indexed.vc/companies/arialys"><img src="https://indexed.vc/api/badge/company/arialys" alt="Arialys on Indexed.vc" width="260" height="76" /></a>